Recent studies on the association of CDKN1B with breast cancer have identified CDKN1B as a driver gene that is almost exclusively mutated in luminal breast cancer (LBC) and found that it is enriched in mutations leading to loss of function in metastatic breast cancer patients [34]. This evidence concerns the gene CDKN1B and CDH1-related diffuse gastric and lobular breast cancer syndrome.